|
Eli Lilly and Co (Judgment of the Court)
|
[2013] EUECJ C-493/12
|
Court of Justice of the European Communities
|
Europe
|
12 Dec 2013
|
BAILII
|
|
|
|
Actavis Group and Actavis (Judgment of the Court)
|
[2013] EUECJ C-443/12
|
Court of Justice of the European Communities
|
Europe
|
12 Dec 2013
|
BAILII
|
|
|
|
Georgetown University (Judgment of the Court)
|
[2013] EUECJ C-484/12
|
Court of Justice of the European Communities
|
Europe
|
12 Dec 2013
|
BAILII
|
|
|
|
Glaxosmithkline Biologicals SA, v Comptroller-General of Patents, Designs and Trade Marks
|
[2013] EUECJ C-210/13
|
Court of Justice of the European Communities
|
Europe
|
14 Nov 2013
|
BAILII
|
|
|
|
Sandoz Ltd v GD Searle LLC
|
[2017] EWHC 987 (Pat)
|
High Court of England and Wales
|
United Kingdom - England and Wales
|
3 May 2017
|
BAILII
|
|
2
|
|
Teva UK Ltd v Gilead Sciences Inc
|
[2017] EWHC 13 (Pat)
|
High Court of England and Wales
|
United Kingdom - England and Wales
|
13 Jan 2017
|
BAILII
|
|
7
|
|
Eli Lilly And Co v Human Genome Sciences Inc
|
[2014] EWHC 2404 (Pat); [2015] RPC 8
|
High Court of England and Wales
|
United Kingdom - England and Wales
|
18 Jul 2014
|
BAILII
|
|
3
|
|
Teva Pharma BV v Amgen, Inc
|
[2013] EWHC 3711 (Pat)
|
High Court of England and Wales
|
United Kingdom - England and Wales
|
27 Nov 2013
|
BAILII
|
|
1
|
